A new report from massive information and technologies enterprise RYAH Medtech, Inc. (RYAH) with regards to health-related cannabis use by females is displaying that the typical female patient prefers strains that are higher in cannabidiol (CBD), delta-9 tetrahydrocannabinol (THC), and strains that are properly-balanced to support treat mental overall health circumstances.
Applying survey feedback from 28,211 females in RYAH’s proprietary information pool and associated insights, the new report finds that females are a expanding segment of the health-related cannabis market place and comprise 45.1 % of the patient population employing RYAH’s information platform.
“The female patient demographic has not received sufficient market interest or study up to this point,” says RYAH CEO Gregory Wagner. “Making up much more than 45% of the patient pool, it is our duty to superior realize what this demographic appears like, which health-related concerns they are in search of therapy for and what remedies are supplying thriving outcomes. Girls are turning to health-related cannabis to treat their overall health issues and it is a worthwhile insight for care providers that we have discovered strains higher in CBD are assisting them get relief.”
Wagner says that health-related cannabis has the capacity to modify lives for the superior and he hopes that insights from RYAH’s information pool and associated evaluation will support strengthen patient outcomes and inspire additional analysis.
In addition to a preference for properly-balanced strains that are higher in CBD and THC, female sufferers demonstrated a practically-equal preference for Indica and Sativa strains.
According to the information, females, like guys, are employing health-related cannabis to treat anxiousness, depression, anxiety, and discomfort.
RYAH compared the present information against other reports on females and cannabis and discovered that females are much more most likely than guys to use cannabis for the distinct therapy of nausea, anorexia, irritable bowel syndrome, migraines, and fibromyalgia.
The reports also indicate that females have a tendency to use health-related cannabis later in life than guys, ordinarily immediately after the age of 30.
According to the report, female sufferers choose Cannatonic, Harlequin, Super Lemon Haze, and Purple Candy for treating anxiousness, and Gorilla Glue (GG#four), Harlequin, Purple Candy, and AC/DC for treating fibromyalgia.